Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Polarean Imaging's cash to debt ratio for the quarter that ended in Jun. 2025 was 16.50.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Polarean Imagingcould pay off its debt using the cash in hand for the quarter that ended in Jun. 2025.
The historical rank and industry rank for Polarean Imaging's Cash-to-Debt or its related term are showing as below:
PLLWF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.87 Med: 28.44 Max: 240.23
Current: 16.5
During the past 9 years, Polarean Imaging's highest Cash to Debt Ratio was 240.23. The lowest was 0.87. And the median was 28.44.
PLLWF's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.68
vs PLLWF: 16.50
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Polarean Imaging Cash-to-Debt Related Terms
Polarean Imaging Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Polarean Imaging's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
PLLWF vs FOFA, BTCY, LFWD: Cash-to-Debt Comparison
For the Medical Devices subindustry, Polarean Imaging's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polarean Imaging (PLLWF) has a Cash-to-Debt of 16.50 as of Jun. 2025. This is 42% below median its historical median of 28.44. Over the past decade, Polarean Imaging's Cash-to-Debt has ranged from 0.87 to 240.23.
Is Polarean Imaging's Cash-to-Debt too high?
Polarean Imaging's current Cash-to-Debt of 16.50 is 42% below median its 10-year median of 28.44. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 240.23. The Medical Devices & Instruments industry median Cash-to-Debt is 1.68. Polarean Imaging's value of 16.50 is 882.1% above this industry median.
How does Polarean Imaging's Cash-to-Debt compare to FOFA and BTCY?
Polarean Imaging's Cash-to-Debt of 16.50 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash-to-Debt is 1.68. Polarean Imaging's value of 16.50 is 882.1% above this benchmark. Historically, Polarean Imaging's own Cash-to-Debt has ranged from 0.87 to 240.23 over the past decade. While the company's 10-year median is 28.44 vs. the industry median of 1.68, Polarean Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.68, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current Cash-to-Debt of 16.50 is 882.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current Cash-to-Debt is 16.50, which is 42% below median its own 10-year median of 28.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current Cash-to-Debt of 16.50. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current Cash-to-Debt is 16.50, which is 42% below median its 10-year median of 28.44 and 882.1% above the Medical Devices & Instruments industry median of 1.68. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current Cash-to-Debt is 16.50 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLLWF has been successfully added to your 
